Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248572 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
A Phase 4 study of Cataract, sponsored by Lenstec Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT01248572: Completed Phase 4 study of Cataract, sponsored by Lenstec Incorporated.
NCT01248572 is a Phase 4 study of Cataract that has completed, run by Lenstec Incorporated. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01248572, a Phase 4 study of Cataract, has completed, sponsored by Lenstec Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary goal of this study is to determine the effective lens position (ELP) - or location an intraocular lens (IOL) "sits" in the eye - of the Softec HD IOL. A secondary study goal is to determine if measures of the eye taken prior to surgery can reliably predict postoperative ELP.
Primary Outcome
The position of the intraocular lens - defined by measurement of the aqueous-containing space between the corneal endothelium and the anterior surface of the intraocular lens - once implanted in the capsular bag.
Conditions Studied
Interventions
- DEVICE Softec HD IOL
Study Locations (3)
Arizona
- Barnet-Dulaney-Perkins Eye Center - Phoenix
Florida
- Eye Centers of Florida - Fort Myers
Georgia
- Harbin Clinic - Rome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
What the finished NCT01248572 record still lists
NCT01248572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Softec HD IOL is the first listed.
NCT01248572 reports a single indexed study location in Arizona, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT01248572 about?
NCT01248572 is a clinical study titled "Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL". The primary goal of this study is to determine the effective lens position (ELP) - or location an intraocular lens (IOL) "sits" in the eye - of the Softec HD IOL. A secondary study goal is to determine if measures of the eye taken prior to surgery can reliably predict postoperative ELP.
What is the current status of trial NCT01248572?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2010-10. Estimated completion is 2012-03.
What conditions does trial NCT01248572 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT01248572?
The interventions under investigation include: Softec HD IOL (DEVICE).
Who is sponsoring clinical trial NCT01248572?
This trial is sponsored by Lenstec Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01248572 being conducted?
This trial has 3 study locations across Arizona, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01248572's enrollment target sits among peer trials
40 65th of 83 higher than 14 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia